PPA
AVNS

Parametric Portfolio Associates’s Avanos Medical AVNS Stock Holding History

Parametric Portfolio Associates’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		$5.4M Buy
161,291
+33,925
+27% +$1.09M ﹤0.01% 1798
2021
Q4 		$4.42M Buy
127,366
+18,538
+17% +$599K ﹤0.01% 1955
2021
Q3 		$3.4M Buy
108,828
+7,920
+8% +$269K ﹤0.01% 2098
2021
Q2 		$3.67M Buy
100,908
+24,984
+33% +$1.03M ﹤0.01% 2063
2021
Q1 		$3.32M Buy
75,924
+2,691
+4% +$126K ﹤0.01% 2448
2020
Q4 		$3.36M Sell
73,233
-2,918
-4% -$121K ﹤0.01% 2335
2020
Q3 		$2.53M Buy
76,151
+1,976
+3% +$63.1K ﹤0.01% 2359
2020
Q2 		$2.18M Sell
74,175
-19,849
-21% -$575K ﹤0.01% 2450
2020
Q1 		$2.53M Buy
94,024
+23,542
+33% +$703K ﹤0.01% 2228
2019
Q4 		$2.38M Sell
70,482
-13,425
-16% -$486K ﹤0.01% 2586
2019
Q3 		$3.14M Sell
83,907
-11,535
-12% -$440K ﹤0.01% 2358
2019
Q2 		$4.16M Sell
95,442
-16,980
-15% -$726K ﹤0.01% 2146
2019
Q1 		$4.8M Sell
112,422
-4,357
-4% -$195K ﹤0.01% 2027
2018
Q4 		$5.23M Sell
116,779
-78,345
-40% -$4.1M 0.01% 1844
2018
Q3 		$13.4M Buy
195,124
+5,994
+3% +$386K 0.01% 1210
2018
Q2 		$10.8M Sell
189,130
-2,279
-1% -$120K 0.01% 1288
2018
Q1 		$8.82M Sell
191,409
-15,147
-7% -$719K 0.01% 1438
2017
Q4 		$9.54M Buy
206,556
+25,293
+14% +$1.16M 0.01% 1358
2017
Q3 		$8.16M Sell
181,263
-25,604
-12% -$1.09M 0.01% 1436
2017
Q2 		$8.13M Sell
206,867
-3,111
-1% -$118K 0.01% 1363
2017
Q1 		$8M Buy
209,978
+28,008
+15% +$1.09M 0.01% 1336
2016
Q4 		$6.73M Sell
181,970
-4,492
-2% -$161K 0.01% 1387
2016
Q3 		$6.46M Buy
186,462
+33,622
+22% +$1.18M 0.01% 1323
2016
Q2 		$4.97M Buy
152,840
+25,003
+20% +$766K 0.01% 1534
2016
Q1 		$3.67M Buy
127,837
+5,441
+4% +$145K 0.01% 1896
2015
Q4 		$4.09M Buy
122,396
+45,888
+60% +$1.43M 0.01% 1561
2015
Q3 		$2.18M Sell
76,508
-19,727
-20% -$688K ﹤0.01% 1782
2015
Q2 		$3.9M Sell
96,235
-59,950
-38% -$2.69M 0.01% 1609
2015
Q1 		$7.68M Buy
156,185
+2,009
+1% +$93.1K 0.02% 955
2014
Q4 		$7.01M Buy
+154,176
New +$6.06M 0.01% 967

Other funds holding AVNS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RC
RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
WHG
Westwood Holdings Group Dallas, Texas $13.7B AUM 21.48% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Parametric Portfolio Associates's AVNS Position: Q1 2022 in Review

Parametric Portfolio Associates increased its Avanos Medical (AVNS) stake by 27% in Q1 2022, buying an estimated $1.09M and bringing the position to 161,291 shares worth $5.4M. The position accounts for ﹤0.01% of the portfolio, ranked #1798.

Parametric Portfolio Associates first reported a position in AVNS in Q4 2014 and has held it in 30 quarters since. The position peaked at $13.4M in Q3 2018. 299 funds tracked by Wall St. Rank hold AVNS as of Q1 2022.

  • Parametric Portfolio Associates held 161,291 shares of Avanos Medical worth $5.4M as of Q1 2022.
  • Parametric Portfolio Associates bought 33,925 Avanos Medical shares in Q1 2022, an estimated $1.09M.
  • Avanos Medical made up ﹤0.01% of Parametric Portfolio Associates's portfolio in Q1 2022, its #1798 holding.
  • Parametric Portfolio Associates first reported a position in Avanos Medical in Q4 2014 and has held it in 30 quarters since.
  • Parametric Portfolio Associates's Avanos Medical position peaked at $13.4M in Q3 2018.
  • 299 funds tracked by Wall St. Rank held Avanos Medical as of Q1 2022.

Based on Parametric Portfolio Associates's 13F filing for Q1 2022, filed 16 May 2022.